Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 31 entries
View as:

Clinical Trial to Investigate the Effects of Food on the Pharmacokinetics and Safety of Orally Administered Radotinib

Phase: N/A Priority: Normal
NCT ID: NCT06461078 Org: User:
Start: 07/22/24 End: 04/28/25 Due: 04/28/26

Phase 1 Study to Assess the Safety of Inactivated Split Influenza Vaccine and Control Vaccine in Korean Volunteer

Phase: N/A Priority: Normal
NCT ID: NCT02330003 Org: User:
Start: 05/31/13 End: 08/31/13 Due: 08/31/14

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole

Phase: N/A Priority: Normal
NCT ID: NCT05237297 Org: User:
Start: 02/17/22 End: 07/27/22 Due: 07/27/23

A Study on Eradication Rate of Triple Therapy According to Treatment Period and CYP2C19 Polymorphisms in H.Pylori Patients

Phase: N/A Priority: Normal
NCT ID: NCT03099876 Org: User:
Start: 03/01/17 End: 12/01/18 Due: 12/01/19

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactivated Split Influenza Vaccine in Healthy Korea Adults

Phase: N/A Priority: Normal
NCT ID: NCT02154308 Org: User:
Start: 11/30/12 End: 08/31/13 Due: 08/31/14

Radotinib Versus Imatinib in Newly Diagnosed Philadelphia Chromosome and Chronic Myeloid Leukemia Chronic Phase Patients

Phase: N/A Priority: Normal
NCT ID: NCT01511289 Org: User:
Start: 08/31/11 End: - Due: -

Immunogenicity and Safety for 'IL-YANG Quadrivalent Influenza Vaccine' in Healthy Korean Children and Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT03445468 Org: User:
Start: 09/20/17 End: 08/30/18 Due: 08/30/19

Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD.

Phase: N/A Priority: Normal
NCT ID: NCT02638584 Org: User:
Start: 12/31/15 End: 03/31/18 Due: 03/31/19

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Clarithromycin, Amoxicillin and Ilaprazole

Phase: N/A Priority: Normal
NCT ID: NCT02998437 Org: User:
Start: 12/31/16 End: 01/31/17 Due: 01/31/18

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac

Phase: N/A Priority: Normal
NCT ID: NCT05558150 Org: User:
Start: 11/10/22 End: 12/22/22 Due: 12/22/23

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

Phase: N/A Priority: Normal
NCT ID: NCT06284876 Org: User:
Start: 07/23/24 End: 02/28/27 Due: 02/28/28

Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults

Phase: N/A Priority: Normal
NCT ID: NCT02480998 Org: User:
Start: 02/28/15 End: 04/30/15 Due: 04/30/16

Study to Evaluate the Immunogenicity and Safety of 'IL-YANG Quadrivalent Influenza Vaccine Inj.'

Phase: N/A Priority: Normal
NCT ID: NCT02677493 Org: User:
Start: 10/31/15 End: 06/30/16 Due: 06/30/17

Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-HCR21 and IY-MIC

Phase: N/A Priority: Normal
NCT ID: NCT06471868 Org: User:
Start: 06/10/24 End: 07/02/24 Due: 07/02/25

Immunogenicity and Safety Study of Inactivated Split Influenza Vaccine' in Healthy Korean Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02111070 Org: User:
Start: 09/30/12 End: 10/31/12 Due: 10/31/13

Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04691661 Org: User:
Start: 09/09/21 End: 12/31/26 Due: 12/31/27

Efficacy Study of Ilaprazole to Treat Erosive Esophgitis

Phase: N/A Priority: Normal
NCT ID: NCT01509261 Org: User:
Start: 07/31/10 End: 06/30/11 Due: 06/30/12

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

Phase: N/A Priority: Normal
NCT ID: NCT05509543 Org: User:
Start: 08/24/22 End: 12/18/23 Due: 12/18/24

Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI

Phase: N/A Priority: Normal
NCT ID: NCT01602952 Org: User:
Start: 07/31/08 End: 07/13/18 Due: 07/13/19

Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection

Phase: N/A Priority: Normal
NCT ID: NCT02401477 Org: User:
Start: 12/31/14 End: 06/30/15 Due: 06/30/16

Efficacy and Safety of Dose Redution of Radotinib as a First Line Treament in Ph+ CML

Phase: N/A Priority: Normal
NCT ID: NCT06665412 Org: User:
Start: 10/24/24 End: 12/31/26 Due: 12/31/27

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

Phase: N/A Priority: Normal
NCT ID: NCT05617651 Org: User:
Start: 11/30/24 End: 12/30/25 Due: 12/30/26

Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)

Phase: N/A Priority: Normal
NCT ID: NCT03722420 Org: User:
Start: 12/28/18 End: 06/30/25 Due: 06/30/26

A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs

Phase: N/A Priority: Normal
NCT ID: NCT03459534 Org: User:
Start: 06/25/18 End: 12/31/27 Due: 12/31/28

Phase 3 Study to Evaluate the Immunogenicity and Safety of Inactived Split Influenza Vaccine in Healthy Korea Infants

Phase: N/A Priority: Normal
NCT ID: NCT04381689 Org: User:
Start: 10/23/24 End: 06/30/25 Due: 06/30/26